Dr. Putnam attended Pittsburg State University as an undergraduate where he majored in Chemistry and conducted research in polymer chemistry. He was also a NSF undergraduate research fellow at the University of Oklahoma where he conducted research in X-ray crystallography under Prof. Dick van der Helm. Dr. Putnam then attended Washington University in St. Louis where he earned a M.S. and Ph.D. in Organic Chemistry under Prof. James K. Bashkin. His research focused on the design and development of artificial ribonucleases as potential novel infectious disease therapeutic agents. Dr. Putnam then moved to the Midwest Research Institute where his research focused on the pharmacology candidate therapeutic agents including developing sensitive analytical and bioanalytical methods. Additional research interests included biomarkers of polycystic kidney disease, catalytic antibodies, and artificial ribonucleases. Dr. Putnam then took an appointment at Texas Tech University Health Sciences Center as an Assistant Professor in the School of Pharmacy. He also served as the laboratory director of the Pediatric Pharmacology Research and Development Center. Dr. Putnam then took a position with Cardinal Health’s Scientific and Regulatory Consulting Division where he provided drug development/regulatory consulting to numerous pharmaceutical companies. Dr. Putnam eventually assumed the role of general manager and was responsible for strategic, managerial, and operational aspects of the business. Dr. Putnam then returned to Texas Tech’s School of Pharmacy as a Professor where he remains today. His current research interests include: clinical pharmacology, differential metabolism of disease states, biomarker identification/validation, and advanced analytical/bioanalytical methodology.

Interests

Cancer
Infectious disease
Kidney cancer
Kidney disease
Pediatrics

Pharmacy Research Interests

LC-MS/MS, LC-UV/VIS, LC-ECD, UPLC-MS/MS
analytical methods
biochemistry
biomarkers
brain tumor
cancer
cancer biology
cancer chemotherapy
cell signaling
clinical pharmacology
diindolylmethane (DIM)
drug delivery
drug delivery systems
drug development
drug discovery
drug efficacy
gel electrophoresis
infectious diseases
macromolecules
medicinal chemistry
oligonucleotide-based drubs
oncology
pathogenesis
pediatric
pediatric clinical pharmacology & therapeutics
pediatric pharmaceutical device development
pediatric pharmacotherapy

�㽶ֱ��

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Trey Campbell Putnam

Contact